CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- 425 Deal Prospectus/Communication re Business Combination
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- SC 13G Stake Amended Statement of Ownership
- DEFR14A Other DEFR14A
- 8-K Event Material agreement · New debt or obligation · Bylaws or fiscal year change · Other events
- 4 Insider Changes in Ownership
- DEF 14A Proxy Proxy Statement
- S-4 Deal Registration Statement - Business Combination
- PRE 14A Proxy Proxy Statement (Preliminary)
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- DEFA14A Proxy Proxy Materials
Page 17 of 20 · 389 filings